Peer Review reports
From: Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
| Original Submission | ||
|---|---|---|
| 15 Feb 2024 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 15 Apr 2024 | Reviewed | Reviewer Report |
| 1 Jul 2024 | Reviewed | Reviewer Report |
| 1 Jul 2024 | Reviewed | Reviewer Report - Sudeep Kumar Kapalavai |
| 16 Jul 2024 | Author responded | Author comments - Brittany Player |
| Resubmission - Version 3 | ||
| 16 Jul 2024 | Submitted | Manuscript version 3 |
| 6 Aug 2024 | Reviewed | Reviewer Report - Sudeep Kumar Kapalavai |
| 23 Aug 2024 | Author responded | Author comments - Brittany Player |
| Resubmission - Version 4 | ||
| 23 Aug 2024 | Submitted | Manuscript version 4 |
| 26 Aug 2024 | Author responded | Author comments - Brittany Player |
| Resubmission - Version 5 | ||
| 26 Aug 2024 | Submitted | Manuscript version 5 |
| Publishing | ||
| 28 Aug 2024 | Editorially accepted | |
| 17 Sep 2024 | Article published | 10.1186/s12879-024-09833-9 |
You can find further information about peer review here.